NCT06550947View on ClinicalTrials.gov

ALDOA Expression in Bladder Urothelial Carcinoma

Not yet recruitingOBSERVATIONAL
Enrollment

50

Participants

Timeline

Start Date

September 30, 2024

Primary Completion Date

July 31, 2025

Study Completion Date

August 31, 2025

Conditions
Bladder Urothelial Carcinoma
Interventions
GENETIC

Immunohistochemistry

Immunohistochemical expression of ALDOA in bladder urothelial carcinoma

All Listed Sponsors
lead

Assiut University

OTHER

NCT06550947 - ALDOA Expression in Bladder Urothelial Carcinoma | Biotech Hunter | Biotech Hunter